|
|
About Eisai Medical Research Inc.
Eisai Medical Research Inc. is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care company that discovers, develops and markets products throughout the world. Eisai Medical Research Inc. was established to focus solely on clinical research and to expedite clinical drug development of new chemical entities and of new indications for marketed products.
Our U.S. operation is responsible for the largest share of Eisai's global clinical development activities. Eisai Medical Research Inc. benefits greatly from collaboration with its colleagues at Eisai Research Institute in Massachusetts and with Eisai's global network of research organizations in the United Kingdom and Japan.
Capitalizing on our global research capabilities, Eisai Medical Research Inc. concentrates resources on three targeted therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care.
Headquartered in Ridgefield Park, N.J., Eisai Medical Research Inc. employs more than 250 people and is continuing to grow. We invite you to apply online!
 Printer Friendly Version
|
|
